Fenofibric acid

Acta Crystallographica Section C: Crystal Structure Communications

Volumn 61, Issue 2, 2005, Pages

  Rath, Nigam P ^a   Haq, Wahajul ^b   Balendiran, Ganesaratnam K ^c  

^a UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACIDS; CONFORMATIONS; ESTERS; HYDROGEN BONDS; KETONES;

FINOFIBRATES; MOLECULAR RECOGNITION;

MOLECULAR STRUCTURE;

DRUG DERIVATIVE; FENOFIBRATE; FENOFIBRIC ACID; HYPOCHOLESTEROLEMIC AGENT;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; HYDROGEN BOND; X RAY CRYSTALLOGRAPHY;

ANTICHOLESTEREMIC AGENTS; CRYSTALLOGRAPHY, X-RAY; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROCETOFEN;

EID: 30944440105     PISSN: 01082701     EISSN: None     Source Type: Journal    
DOI: 10.1107/S0108270104032573     Document Type: Article

References (26)

1. Abell, A. D., Morris, K. B. & McKee, V. (1990). Aust. J. Chem. 43, 765-771.
2. Abell, A. D., Trent, J. O. & Robinson, W. T. (1991). J. Chem. Soc. Chem. Commun, pp. 362-363.
3. Adkins, J. C. & Faulds, D. (1997). Drugs, 54, 615-633.
4. Allen, F. H. (2002). Acta Cryst. B58, 380-388.
5. Armstrong, A., Critchley, T. J., Gourdel-Martin, M.-E., Kelseley, R. D. & Mortlock, A. A. (2002). Tetrahedron Lett. 43, 6027.
6. Barcon, A., Brunskill, A. P., Lalancette, R. A. & Thompson, H. W. (2002). Acta Cryst. C58, o154-o156.
7. Bruker (2003). SMART and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
8. Coté, M. L., Lalancette, R. A. & Thompson, H. W. (1996). Acta Cryst. C52, 1535-1537.
9. Forcheron, F., Cachefo, A., Thevenon, S., Pinteur, C. & Beylot, M. (2002). Diabetes, 51, 3486-3491.
10. Griffe, M., Durant, F. & Pieret, A. F. (1972). Bull. Soc. Chim. Belg. 81, 319-332.
11. Guay, D. R. (1999). Ann. Pharmacother. 33, 1083-1103.
12. Halfpenny, J. (1990). Acta Cryst. C46, 2487-2489.
13. Henry, R. F., Zhang, G. Z., Gao, Y. & Buckner, I. S. (2003). Acta Cryst. ES9, o699-o700.
14. Keating, G. M. & Ormrod, D. (2002). Drugs, 62, 1904-1944.
15. Kosela, S., Yulizar, Y., Chairul, Tori, M. & Asakawa, Y. (1995). Phytochemistry, 38, 691-694.
16. Lalancette, R. A., Thompson, H. W. & Brunskill, A. P. J. (1998). Acta Cryst. C54, 421-424.
17. Leiserowitz, L. (1976). Acta Cryst. B32, 775-802.
18. Miller, D. B. & Spence, J. D. (1998). Clin. Pharmacokin. 34, 155-162.
19. Newman, J. M., Papadakis, M. M., Thompson, H. W. & Lalancette, R. A. (2002). Acta Cryst. C58, m89-m91.
20. Nuhrich, A., Beranger, M., Devaux, G., Cambar, J., Dorian, C. & Carpy, A. (1986). Eur. J. Med. Chem. 21, 49-54.
21. Peters, O. M., Blaton, N. M. & De Ranter, C. J. (1983). Bull. Soc. Chim. Belg. 93, 191-192.
22. Sheldrick, G. M. (2003). SHELXTL. Bruker AXS Inc., Madison, Wisconsin, USA.
23. Sheldrick, W. S. & Trowitzsch, W. (1983). Z. Naturforsch. Teil B, 38, 220-225.
24. Streel, B., Hubert, P. & Ceccato, A. (2000). J. Chromatogr. B, 742, 391-400.
25. Taniguchi, A., Fukushima, M., Sakai, M., Tokuyama, K., Nagata, I., Fukunaga, A., Kishimoto, H., Doi, K., Yamashita, Y., Matsuura, T., Kitatani, N., Okumura, T., Nagasaka, S., Nakaishi, S. & Nakai, Y. (2001). Metabolism, 50, 477-480.
26. Throp, J. M. (1962). Lancet, 1, 1323-1326.